Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 418

Results For "IT"

11166 News Found

Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits
Sustainability | August 09, 2021

Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits

This work has been published in the journal ‘ACS applied materials and interface’


Abbott India net profit rises to 8.5 per cent in Q1FY22
News | August 08, 2021

Abbott India net profit rises to 8.5 per cent in Q1FY22

PAT rises to Rs 195.76 crore


TAKE divests stake in Navitas Life Sciences to HIG
Biotech | August 08, 2021

TAKE divests stake in Navitas Life Sciences to HIG

The transaction is expected to close in the Q4FY22


Cipla posts  net profit at Rs 715 crores
News | August 08, 2021

Cipla posts net profit at Rs 715 crores

India business contributes to a stellar performance


Strides to acquire US manufacturing facility of Endo for $24 mn
News | August 06, 2021

Strides to acquire US manufacturing facility of Endo for $24 mn

The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.


India’s gets its first bio-bank for heart failure research
Drug Approval | August 06, 2021

India’s gets its first bio-bank for heart failure research

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology


Apollo Hospitals successfully implants MitraClip
Healthcare | August 05, 2021

Apollo Hospitals successfully implants MitraClip

MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery


Novavax signs agreement with European Commission for COVID19 vaccine
Biotech | August 05, 2021

Novavax signs agreement with European Commission for COVID19 vaccine

Deal for 100 million doses with additional 100 million through 2023


Dr. Reddy's Laboratories signs asset purchase agreement with BioDelivery Sciences
News | August 05, 2021

Dr. Reddy's Laboratories signs asset purchase agreement with BioDelivery Sciences

Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing